Maria Kuzmina: How Chronic Inflammation Affects Extramedullary Hematopoiesis
Maria Kuzmina, Clinical Biochemist, Immunologist at Institute of Molecular Genetics of the Czech Academy of Sciences, shared on LinkedIn about a recent article she and her colleagues co-authored, published in Science Advances, adding:
”It’s been a week and it still feels a bit surreal to see it out there.
My PhD research has been p5gublished in Science Advances (Science Magazine)!
Publishing in a journal like this was a goal I set at the very beginning of my PhD and it’s what kept me going when things were tough.
This wouldn’t have been possible without the guidance of my supervisor Meritxell Alberich-Jordà and an incredible team of collaborators from Institute of Molecular Genetics of the Czech Academy of Sciences and beyond.
In this work, we studied how chronic inflammation affects extramedullary hematopoiesis, an area that is still relatively poorly understood.
We show that hematopoietic stem and progenitor cells are not just passively relocated under stress.
Instead, they actively adapt and establish a bidirectional interaction with Tregs – promoting their development while being protected by them in return.
Furthermore, our findings suggest that chronic inflammation can reshape normally inactive bone marrow niches into functional hematopoietic sites, even in unexpected locations such as inflamed paws.
Altogether, this suggests that blood formation is not simply relocated during stress, but locally adapted in ways we are only beginning to understand.”
Title: HSPCs and Treg cells cooperate to preserve extramedullary hematopoiesis under chronic inflammation
Authors: Maria Kuzmina, Srdjan Grusanovic, Jiri Brezina, Flavian Thelen, Karolina Vanickova, Mirko Milosevic, Irina Ribeiro Bas, Nataliiia Pavliuchenko, Sarka Ruzickova, Jakub Rohlena, Dominik Filipp, Katerina Rohlenova, Cesar Nombela-Arrieta, Tomas Brdicka, Meritxell Alberich-Jorda
Stay updated with Hemostasis Today.
-
Jun 10, 2026, 18:22Winai Porntipworawech: The $50 Life-Saving Drug Big Pharma Doesn’t Want You to See
-
Jun 10, 2026, 18:09Leonard Valentino: Innovation in Blood Disorders Being Catalyzed by Pathway to Cures
-
Jun 10, 2026, 18:00Smitirupa Mishra: Normal Hemoglobin Does Not Always Mean Normal Genes
-
Jun 10, 2026, 17:58Talat Uppal: Addressing HMB with RACGP’s Dr. Ramya Raman
-
Jun 10, 2026, 17:52Throw Back Thursday to Past Bruises Posted in the Glanzmann’s Research Foundation
-
Jun 10, 2026, 17:52Priya Prasad: In Massive Hemorrhage, Fibrinogen Is Often the First Clotting Factor to Fall
-
Jun 10, 2026, 17:51Mariam Swidan: Some Red Blood Cells Can’t Handle Pressure
-
Jun 10, 2026, 17:49Ankit Mathur: Hosting ISBT Academy Day on Rare Donor Program in India
-
Jun 10, 2026, 17:48Shadi Tabibian: When Patients Bleed but Standard Testing Is Normal